These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11030639)
21. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Storr M; Allescher HD; Rösch T; Born P; Weigert N; Classen M Gastrointest Endosc; 2001 Dec; 54(6):754-9. PubMed ID: 11726856 [TBL] [Abstract][Full Text] [Related]
22. Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Greaves RR; Mulcahy HE; Patchett SE; Gorard DA; Fairclough PD; Alstead EM; Farthing MJ Aliment Pharmacol Ther; 1999 Sep; 13(9):1221-5. PubMed ID: 10468705 [TBL] [Abstract][Full Text] [Related]
24. Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia: a pilot trial. Wehrmann T; Schmitt T; Dietrich CF; Caspary WF; Seifert H Z Gastroenterol; 2000 Nov; 38(11):899-903. PubMed ID: 11132536 [TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin. Brisinda G; Civello IM; Albanese A; Maria G Curr Med Chem; 2003 Apr; 10(7):603-23. PubMed ID: 12678792 [TBL] [Abstract][Full Text] [Related]
26. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia. Katzka DA; Castell DO Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644 [TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin for spastic GI disorders: a systematic review. Zhao X; Pasricha PJ Gastrointest Endosc; 2003 Feb; 57(2):219-35. PubMed ID: 12556788 [No Abstract] [Full Text] [Related]
28. Current trends in the management of achalasia. Bruley des Varannes S; Scarpignato C Dig Liver Dis; 2001 Apr; 33(3):266-77. PubMed ID: 11407673 [TBL] [Abstract][Full Text] [Related]
29. The role of Botulinum toxin injection in the management of achalasia. Ramzan Z; Nassri AB Curr Opin Gastroenterol; 2013 Jul; 29(4):468-73. PubMed ID: 23695428 [TBL] [Abstract][Full Text] [Related]
30. [Intrasphincteric injection of botulinum toxin in patients with esophageal achalasia]. Zapata R; Carvajal S; Alvarez M; González R; Chianale J; Rollán A Rev Med Chil; 1997 Aug; 125(8):899-904. PubMed ID: 9567393 [TBL] [Abstract][Full Text] [Related]
31. In-office transnasal esophagoscope-guided botulinum toxin injection of the lower esophageal sphincter. Rees CJ Curr Opin Otolaryngol Head Neck Surg; 2007 Dec; 15(6):409-11. PubMed ID: 17986880 [TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin may predict the outcome of endoscopic sphincterotomy in episodic functional post-cholecystectomy biliary pain. Murray W; Kong S Scand J Gastroenterol; 2010 May; 45(5):623-7. PubMed ID: 20156033 [TBL] [Abstract][Full Text] [Related]
38. Botulinum Toxin A Use in the Gastrointestinal Tract: A Reappraisal After Three Decades. Mohajir WA; Khurana S; Singh K; Chong RW; Bhutani MS Gastroenterol Hepatol (N Y); 2023 Apr; 19(4):198-212. PubMed ID: 37705841 [TBL] [Abstract][Full Text] [Related]
39. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Pullman SL; Greene P; Fahn S; Pedersen SF Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169 [TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]